Business Context and Reporting Period
Company: United States Antimony Corporation (UAMY)
Filing Type: Form 8-K (Current Report)
Date of Report: September 17, 2025
Principal Executive Offices: Dallas, TX
Reporting Period: This filing reports a specific corporate event occurring on September 17, 2025, rather than a financial reporting period.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing focuses exclusively on a capital raising mechanism.
Material Changes and Events
- Amended Sales Agreement: The Company entered into an Amended and Restated Sales Agreement with A.G.P./Alliance Global Partners and added B. Riley Securities, Inc. as a new sales agent.
- ATM Program Expansion: The Company filed a prospectus supplement to increase the amount of common stock issuable under the "at the market" (ATM) offering program to up to $65,000,000.
- Commission Structure: The Company agreed to pay the sales agents a commission of up to 3.0% of the gross proceeds from share sales.
- Termination of Prior Offering: The offering of common stock pursuant to the prospectus supplement dated April 25, 2025, was terminated.
Guidance, Outlook, and Risks
- Management Discretion: The Company has no obligation to sell any shares under the agreement and may suspend solicitations at its sole discretion.
- Sales Parameters: The Company retains the right to set parameters for sales, including maximum share amounts, time periods, daily limits, and minimum prices.
- Legal Contingencies: The Company provided customary representations, warranties, and indemnification obligations to the sales agents regarding liabilities under the Securities Act and the Exchange Act of 1934.
Investor Verification Checklist
- Verify the current share price and trading volume to assess the potential dilution impact of a $65 million ATM program.
- Review the full text of the Amended and Restated Sales Agreement (Exhibit 1.1) for specific minimum price floors or daily sales limits.
- Confirm the Company's current cash position and debt levels to understand the necessity of this capital raise.
- Monitor future filings for actual sales activity under the new agreement to gauge market reception.